Gilead Sciences to buy CGI Pharma for up to $120M – BusinessWeek
By Dr. Matthew Watson
Genetic Engineering News | Gilead Sciences to buy CGI Pharma for up to $120M BusinessWeek Biotechnology company Gilead Sciences Inc. said Friday it will acquire the privately held development-stage drug company CGI Pharmaceuticals for up to $120 ... Biotech firm to phase out 150 jobsNews & Observer Gilead Buys CGI for Up To $120MXconomy |
Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research